4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-000403
Chair and CEO sold 25,580 shares at an average $69.85 ($1,786,644)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $22.76 | $426,750 | 403,710 | D |
| 2025-01-02 | Sale : show line 2 in the form 10b5-1 | −18,750 | $69.84 | $1,309,500 | 384,960 | D |
| 2025-01-02 | Exercise or conversion : show line 3 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-01-02 | Sale : show line 4 in the form 10b5-1 | −6,830 | $69.86 | $477,144 | 233,924 | I |
| Open-market sales · 25,580 sh · avg $69.85 · $1,786,644 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-02 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −18,750 | 93,750 | D |
| 2025-01-02 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 225,460 | I |
Loading xslF345X05/wk-form4_1735948354.xml…